About
Kim joined Novo A/S in 2000. He is a member of the Board of Directors of Akebia Therapeutics Inc. and Orphazyme ApS, and a member of the editorial board of Expert Opinion on Therapeutic Patents. Previously, he was a board member of Core A/S, F-star GmbH, Neurokey A/S, Novexel S.A., Nuevolution A/S and Symphogen A/S. Prior to joining Novo A/S, Kim spent five years with Novo Nordisk A/S in positions ranging from Patent Portfolio Analyst to Principal Scientific Analyst. His international experience includes research and venture fund experience in San Francisco, USA, and research experience in Osaka, Japan. Kim is an intellectual property expert and holds a PhD in organic chemistry from the University of Copenhagen and an MSc in chemistry/business administration from Odense University.
Investment Focus
- Location
- Copenhagen, Denmark
Contact Information
Find more investors like Kim
Search Investors